Drugs that contain Hydrogen Peroxide

1. List of Eskata drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7381427 ACLARIS Seborrheic keratosis treatment
Jun, 2022

(11 months ago)

US10098910 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US9980983 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US10493103 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US10729720 ACLARIS Peroxide formulations and methods and applicators for using the same
Apr, 2035

(11 years from now)

US9675639 ACLARIS Peroxide formulations and methods and applicators for using the same
Jul, 2035

(12 years from now)

Do you want to check out ESKATA patents from before 2022?

Market Authorisation Date: 14 December, 2017

Treatment: Treatment of seborrheic keratoses that are raised

Dosage: SOLUTION;TOPICAL

More Information on Dosage

ESKATA family patents

14

United States

3

Australia

2

China

2

Canada

2

Brazil

2

Singapore

2

Mexico

2

Japan

2

European Union

1

New Zealand

1

Korea, Republic of

1

Germany

1

Russia

1

Austria

1

Spain

1

Israel

1

Portugal

1

Denmark

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic